Immunotoxins: the power and the glory

This publication has 8 references indexed in Scilit:

• Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide
  Blood, 1992
• Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor
  Blood, 1992
• The crystal structure of diphtheria toxin
  Nature, 1992
• Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin
  The Lancet, 1992
• The specific cytotoxicity of immunoconjugates containing blocked ricin is dependent on the residual binding capacity of blocked ricin: Evidence that the membrane binding and A-chain translocation activities of ricin cannot be separated
  Biochemical and Biophysical Research Communications, 1992
• Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion
  Blood, 1992
• Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor
  Brain Research, 1991
• Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia
  The Lancet, 1991